Monoclonal Antibody to BH3 Interacting Domain Death Agonist (Bid) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
RPA629Hu01-Recombinant BH3 Interacting Domain Death Agonist (Bid)
Recommended Usage
Western blotting: 0.1-2μg/mL; < br/> Immunohistochemistry: 5-20μg/mL; < br/> Immunocytochemistry: 5-20μg/mL; < br/> Optimal working dilutions must be determined by end user.
